The Citing articles tool gives a list of articles citing the current article. The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Evaluation of coagulation factors and platelet function from an off-line modified ultrafiltration technique for post-cardiopulmonary bypass circuit blood recovery
Outcomes and Biochemical Parameters Following Cardiac Surgery: Effects of Transfusion of Residual Blood Using Centrifugation and Multiple-Pass Hemoconcentration
Erick McNair, William McKay, Abdul Mohamed Qureshi, Mark Rosin, Jon Gamble, Greg Dalshaug, Taras Mycyk and Kailash Prasad Journal of Cardiothoracic and Vascular Anesthesia 27(6) 1174 (2013) https://doi.org/10.1053/j.jvca.2013.03.011
Changes in Mechanical Fragility and Free Hemoglobin Levels after Processing Salvaged Cardiopulmonary Bypass Circuit Blood with a Modified Ultrafiltration Device
Sarah K. Harm, Jonathan H. Waters, Pamela Lynn, Robert Dyga, Jay S. Raval, Ross F. DiMarco and Mark H. Yazer The Journal of ExtraCorporeal Technology 44(1) 21 (2012) https://doi.org/10.1051/ject/201244021
The Hemobag: the modern ultrafiltration system for patients undergoing cardiopulmonary by pass
Improved Coagulation and Blood Conservation in the Golden Hours After Cardiopulmonary Bypass
Scott R. Beckmann, Dee Carlile, Randall C. Bissinger, M. Burrell, Thomas Winkler and William W. Shely The Journal of ExtraCorporeal Technology 39(2) 103 (2007) https://doi.org/10.1051/ject/200739103
Use of the Hemobag® for Modified Ultrafiltration in a Jehovah’s Witness Patient Undergoing Cardiac Surgery
David M. Moskowitz, James J. Klein, Aryeh Shander, Seth I. Perelman, Kirk A. McMurtry, Katherine M. Cousineau and M. Arisan Ergin The Journal of ExtraCorporeal Technology 38(3) 265 (2006) https://doi.org/10.1051/ject/200638265
A new practical technique to reduce allogeneic blood exposure and hospital costs while preserving clotting factors after cardiopulmonary bypass: the Hemobag®